BioWorld

Aug. 29, 2003

View Archived Issues

Amgen, Genentech Legal War Ends With Payout Settlement

Exploring Brain Neurons In Rats, Fish Rebuts Dogma That Memory Molecules Consolidate Only Once

As IPO Market Improves, Aderis Tries Again, Now Seeking $75M

Holiday notice

Berlex Planning Phase III Study Of Leukine In Crohn's Patients

Other News To Note

Corrections

Myogen Raises $40M Privately, Then Registers For $70M IPO

Falling in step with others in the industry, Myogen Inc. Thursday afternoon said it registered for an initial public offering, estimating it would raise $75 million. (BioWorld Today) Read More

Today's news in brief

BioWorld

BioWorld briefs for Dec. 17, 2025.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for Dec. 17, 2025.

CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials

BioWorld

A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...

European Commission floats multiple fixes for MDR, IVDR

BioWorld MedTech

The European Union’s struggles with regulations for devices and in vitro diagnostics seem virtually endless, but the European Commission floated a series of...

Left: Anthony Fauci. Right: Transmission electron micrograph of HIV-1 virus particles

HIV research is close to a cure but far from ending the pandemic

BioWorld

Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...